RIO DE JANEIRO, May 7. /TASS/. Uniao Quimica will start producing the Sputnik V coronavirus vaccine in Brazil before the national regulator (Anvisa) gives its approval, CEO of the Brazilian pharmaceutical company Fernando Marques said on Friday.
"We will get a batch of the active component from Moscow next week and will start bottling the vaccine at the plant in Guarulhos," he said. "We will start production immediately after receiving components and will await registration enabling us to start its use in the country," Marques noted.
Production of the active component in Brazil is to start after receiving a conclusion from the Gamaleya Research Center, the vaccine developer, the top manager said. "We will receive equipment in late May, making it possible to scale up production volumes," he added.
Brazil’s National Health Surveillance Agency (Anvisa) has not approved the use of Russia’s vaccine so far.